Skba Capital Management LLC Bristol Myers Squibb CO Transaction History

Skba Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $177,526 - $201,280	3,700 New	3,700 $200,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $30,740 - $36,860	-500 Reduced 11.9%	3,700 $270,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $29,670 - $33,370	500 Added 13.51%	4,200 $265,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $213,638 - $242,091	3,700 New	3,700 $230,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Skba Capital Management LLC with notifications on news.